Biography

Heather Wolfe, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in leukemia and lymphoma, and her clinical interests include cancer survivorship, chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma, and other indolent lymphomas.

Dr. Wolfe earned her medical degree at Indiana University, where she also earned a master’s degree in biology. She completed a residency in internal medicine at UT Southwestern, where she served as Chief Resident, then gained advanced training in hematology and oncology at Duke University, where she was Chief Fellow.

Certified by the American Board of Internal Medicine, Dr. Wolfe joined the UT Southwestern faculty in 2022.

She is the Director of CLL Survivorship at UT Southwestern.

Dr. Wolfe is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the Texas Medical Association.

Her research interests include cancer survivorship, quality-of-life improvement in patients with CLL and lymphoma, and novel therapies and patient-centered outcomes for lymphoma and leukemia. She has published several articles in peer-reviewed journals related to these topics.

In 2021, Dr. Wolfe was named Fellow of the Year by the North Carolina Oncology Association.

Personal Note

Outside of work, Dr. Wolfe enjoys traveling, cooking, gardening, and spending time with her family.

Education & Training
  • Medical School - Indiana University School of Medicine (2011-2015)
  • Internship - UT Southwestern Medical Center (2015-2016), Internal Medicine
  • Residency - UT Southwestern Medical Center (2016-2018), Internal Medicine
  • Fellowship - Duke University Medical Center (2019-2022), Hematology Oncology
Professional Associations & Affiliations
  • American Society of Clinical Oncology
  • American Society of Hematology
  • Texas Medical Association
Honors & Awards
  • Fellow of the Year 2021, North Carolina Oncology Association
Books & Publications
Research
  • Cancer survivorship
  • Novel therapies/drug combinations
  • Patient-centered outcomes
  • Quality-of-life improvements in patients with chronic lymphocytic leukemia (CLL) and lymphoma

Clinical Focus

  • Cancer Survivorship
  • Chronic Lymphocytic Leukemia
  • Hematologic Malignancies
  • Hematology and Oncology
  • Indolent Lymphomas
  • Small Lymphocytic Lymphoma

See More

Heather Wolfe, M.D.

Dr. Wolfe talks about her approach to patient care.